Thanaphon Anutraungkool
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Thanaphon Anutraungkool has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Charoen Choonhakarn
Division of Dermatology, Department of Medicine, Faculty of Medicine Khon Kaen University Khon Kaen Thailand
2 shared publications - Narachai Julanon
Division of Dermatology, Department of Medicine, Srinagarind Hospital, Khon Kaen University, Khon Kaen 40002, Thailand
2 shared publications - Rachot Wongjirattikarn
Division of Dermatology, Department of Medicine, Faculty of Medicine Khon Kaen University Khon Kaen Thailand
2 shared publications - Suteeraporn Chaowattanapanit
Division of Dermatology, Department of Medicine, Faculty of Medicine Khon Kaen University Khon Kaen Thailand
2 shared publications - Chanita Unhapipatpong
Division of Gastroenterology, Department of Medicine, Toronto General Hospital, University of Toronto, Toronto, ON M5G 2C4, Canada
1 shared publication Christos C. Zouboulis
Department of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Dessau, Germany
1 shared publication
Latest Publications
- 29 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8) , 1142-1152
Incidence Trends and Severe in‐Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study
Contemporary population‐based data on incidence trends and in‐hospital outcomes of pemphigus vulgaris remain limited, particularly in Southeast Asia. This study aimed to characterize incidence patterns and identify factors associated with severe in‐hospital outcomes. We conducted a nationwide retrospective cohort study using Thailand's national administrative health database from 2015 to 2024. Incident cases were defined using a two‐year washout period. Crude and age‐standardized incidence rates were estimated, and temporal trends were evaluated using Poisson regression. Hospitalization analyses were restricted to index hospitalizations. Severe in‐hospital outcomes were defined as a composite of in‐hospital mortality, invasive mechanical ventilation, renal replacement therapy, or shock. Associations with severe in‐hospital outcomes were evaluated using multivariable logistic regression, with sensitivity analyses accounting for repeated admissions using generalized estimating equations. A total of 2 542 incident adult cases were identified, corresponding to a mean annual incidence of 6.03 per 1 000 000 population. Incidence increased over time (adjusted incidence rate ratio 1.20; 95% CI 1.18–1.22), was higher with advancing age, and among females (female‐to‐male ratio 1.41:1). Increasing age‐standardized incidence rates suggested that the temporal increase was not fully explained by population aging. This trend was accompanied by increasing annual hospitalizations. Among 1 537 index hospitalizations, 8.1% experienced severe in‐hospital outcomes. Acute kidney injury, malnutrition, and infection were associated with severe in‐hospital outcomes. In sensitivity analyses accounting for repeated admissions, advancing age and cardiovascular comorbidity were also associated with increased risk. Pemphigus vulgaris demonstrates a rising incidence beyond the effects of population aging, accompanied by increasing hospitalizations and a growing burden of severe in‐hospital outcomes. These findings support early identification of high‐risk patients and appropriate clinical management.
- 29 May 2026
- Published by Wiley in The Journal of Dermatology
- Vol. 53 (8) , 1142-1152
Incidence Trends and Severe in‐Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study
Contemporary population‐based data on incidence trends and in‐hospital outcomes of pemphigus vulgaris remain limited, particularly in Southeast Asia. This study aimed to characterize incidence patterns and identify factors associated with severe in‐hospital outcomes. We conducted a nationwide retrospective cohort study using Thailand's national administrative health database from 2015 to 2024. Incident cases were defined using a two‐year washout period. Crude and age‐standardized incidence rates were estimated, and temporal trends were evaluated using Poisson regression. Hospitalization analyses were restricted to index hospitalizations. Severe in‐hospital outcomes were defined as a composite of in‐hospital mortality, invasive mechanical ventilation, renal replacement therapy, or shock. Associations with severe in‐hospital outcomes were evaluated using multivariable logistic regression, with sensitivity analyses accounting for repeated admissions using generalized estimating equations. A total of 2 542 incident adult cases were identified, corresponding to a mean annual incidence of 6.03 per 1 000 000 population. Incidence increased over time (adjusted incidence rate ratio 1.20; 95% CI 1.18–1.22), was higher with advancing age, and among females (female‐to‐male ratio 1.41:1). Increasing age‐standardized incidence rates suggested that the temporal increase was not fully explained by population aging. This trend was accompanied by increasing annual hospitalizations. Among 1 537 index hospitalizations, 8.1% experienced severe in‐hospital outcomes. Acute kidney injury, malnutrition, and infection were associated with severe in‐hospital outcomes. In sensitivity analyses accounting for repeated admissions, advancing age and cardiovascular comorbidity were also associated with increased risk. Pemphigus vulgaris demonstrates a rising incidence beyond the effects of population aging, accompanied by increasing hospitalizations and a growing burden of severe in‐hospital outcomes. These findings support early identification of high‐risk patients and appropriate clinical management.
- Open Access
- 19 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Role of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials
Background: Dysregulation of the skin microbiome is implicated in acne pathogenesis. Objective: To evaluate the efficacy of probiotics in the management of acne. Methods: Searches were conducted in 3 databases through June 30, 2024. Clinical trials that compared probiotics with controls and investigated their efficacy in acne were included. Primary outcomes were standardized mean differences (SMDs) for the change from baseline to posttreatment in total lesion count (TLC), noninflammatory lesion count (NILC), and inflammatory lesion count (ILC). Secondary outcomes included Global Acne Grading System (GAGS) scores, Investigator’s Global Assessment, erythema, and sebum levels. Results: Thirteen studies comprising 18 study arms and 1453 participants were included. There were no significant reductions in TLC (SMD, −0.22; 95% confidence interval [CI]: −0.50 to 0.07; I 2 = 75%), NILC (SMD, −0.20; 95% CI: −0.48 to 0.08; I 2 = 72%), or ILC (SMD, −0.13; 95% CI: −0.34 to 0.09; I 2 = 52%) with probiotics compared with controls. However, oral probiotics were associated with a significant reduction in GAGS scores (SMD, −0.47; 95% CI: −0.81 to −0.13; I 2 = 67%) versus controls. Subgroup analyses indicated that this effect was most prominent in mild-to-moderate acne patients who received oral probiotics containing Lactobacillus species combined with other strains for a minimum of 12 weeks. Conclusions: Probiotics did not demonstrate a significant reduction in acne lesion counts. However, they were associated with improvements in acne severity as measured by GAGS scores. These findings should be interpreted with caution given the heterogeneity across studies and the fluctuating natural course of acne.
- 19 May 2026
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 30 (5)
Open AccessRole of Probiotics in Managing Acne Vulgaris: A Systematic Review and Meta-Analysis of Clinical Trials
Background: Dysregulation of the skin microbiome is implicated in acne pathogenesis. Objective: To evaluate the efficacy of probiotics in the management of acne. Methods: Searches were conducted in 3 databases through June 30, 2024. Clinical trials that compared probiotics with controls and investigated their efficacy in acne were included. Primary outcomes were standardized mean differences (SMDs) for the change from baseline to posttreatment in total lesion count (TLC), noninflammatory lesion count (NILC), and inflammatory lesion count (ILC). Secondary outcomes included Global Acne Grading System (GAGS) scores, Investigator’s Global Assessment, erythema, and sebum levels. Results: Thirteen studies comprising 18 study arms and 1453 participants were included. There were no significant reductions in TLC (SMD, −0.22; 95% confidence interval [CI]: −0.50 to 0.07; I 2 = 75%), NILC (SMD, −0.20; 95% CI: −0.48 to 0.08; I 2 = 72%), or ILC (SMD, −0.13; 95% CI: −0.34 to 0.09; I 2 = 52%) with probiotics compared with controls. However, oral probiotics were associated with a significant reduction in GAGS scores (SMD, −0.47; 95% CI: −0.81 to −0.13; I 2 = 67%) versus controls. Subgroup analyses indicated that this effect was most prominent in mild-to-moderate acne patients who received oral probiotics containing Lactobacillus species combined with other strains for a minimum of 12 weeks. Conclusions: Probiotics did not demonstrate a significant reduction in acne lesion counts. However, they were associated with improvements in acne severity as measured by GAGS scores. These findings should be interpreted with caution given the heterogeneity across studies and the fluctuating natural course of acne.